 |
Acta Radiol
- JENDEBERG J, Bjorkman A, Dahlman P, Eklof H, et al
Computed tomography urography in macroscopic hematuria: a retrospective study
with implications for standard care pathway.
Acta Radiol. 2026;67:227-236.
PubMed
Abstract available
Actas Urol Esp (Engl Ed)
- TUNCEKIN A, Aktas Y
The role of systemic inflammatory and prognostic indices in diabetic patients
with non-muscle invasive bladder cancer receiving BCG therapy.
Actas Urol Esp (Engl Ed). 2026 Feb 12:501925. doi: 10.1016/j.acuroe.2026.501925.
PubMed
Abstract available
Adv Sci (Weinh)
- SHANGGUAN W, Li W, Huang W, Wu J, et al
FomA-Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate
Bladder Cancer Lymphatic Metastasis via IL-6-Dependent M2b Macrophage
Polarization.
Adv Sci (Weinh). 2026 Feb 13:e23256. doi: 10.1002/advs.202523256.
PubMed
Abstract available
Am J Cancer Res
- ZHANG X, Fu Y, Du Y, Xiong W, et al
CCT5 as a candidate biomarker in bladder cancer: functional validation and
mechanistic clues.
Am J Cancer Res. 2026;16:51-69.
PubMed
Abstract available
Am J Ind Med
- RYOO SW, Choi BY, Son SY, Lee JH, et al
Occupational Exposure to Welding Fumes and the Risk of Bladder Cancer: A
Systematic Review and Meta-Analysis.
Am J Ind Med. 2026 Feb 15. doi: 10.1002/ajim.70062.
PubMed
Abstract available
Ann Oncol
- ZHU Y, Jiang S, Shi Y, Wang S, et al
Sacituzumab tirumotecan in participants with advanced or metastatic urothelial
carcinoma and disease progression after chemotherapy and immune checkpoint
inhibitors.
Ann Oncol. 2026;37:378-387.
PubMed
Abstract available
Ann Surg Oncol
- LIU Q, Huang J
ASO Author Reflections: Augmenting Contrast-Enhanced Ultrasound: A Quantitative
Approach to Predict Muscle-Invasive Bladder Cancer.
Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19236.
PubMed
- AYDOGDU C, McSweeney ST, Packiam VT, Bukavina L, et al
ASO Practice Guidelines Series: Surgical Management of Bladder Cancer Relapse.
Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19129.
PubMed
Abstract available
Apoptosis
- LIN Z, Zhao K, Wang S, Liu J, et al
Oncogenic and immunological roles of LAMP5 across cancers and its potential
utility in bladder cancer.
Apoptosis. 2026;31:65.
PubMed
Abstract available
Arch Med Sci
- YANG Y, Wang F, Ning W, Ding Y, et al
CircRNA_103809/miR-516a/FBXL18 contributes to stemness and gemcitabine resistance
of bladder cancer cells.
Arch Med Sci. 2025;21:2766-2782.
PubMed
Abstract available
- XU X, Gu W, Zakeri MA, Chen YH, et al
No genetic causal links detected between antihypertensive medications and bladder
cancer: insights from a trans-ancestry, drug-target Mendelian randomization
analysis.
Arch Med Sci. 2025;21:2856-2863.
PubMed
Asian Pac J Cancer Prev
- SHIBEL PE, Elyamany AM, El Shorbagy G, Abd Elmaogod EA, et al
Exploring the Role Of CD155 in Urothelial Carcinoma of the Urinary Bladder: An
Immunohistochemical Study & Its Correlation With PD-L1.
Asian Pac J Cancer Prev. 2026;27:667-675.
PubMed
Abstract available
- ABDEL-HAKEEM SS, Abdel-Hakeem SS, Kamal FMM
Crosstalk between ZEB1 expression and CD163+ Tumor-Associated Macrophages in
Muscle-Invasive Urothelial Carcinoma.
Asian Pac J Cancer Prev. 2026;27:499-507.
PubMed
Abstract available
Biochim Biophys Acta Mol Basis Dis
- LIU J, Luo Y, Chen L, Xiong W, et al
Urinary microbiome and metabolomic profiling reveal propionic acid as an enhancer
of BCG immunotherapy in bladder cancer.
Biochim Biophys Acta Mol Basis Dis. 2026;1872:168192.
PubMed
Abstract available
Biochim Biophys Acta Rev Cancer
- KUANG J, An Y, Zhang X, He Z, et al
Analysis of bladder cancer therapeutic drug clinical trials in mainland China and
globally.
Biochim Biophys Acta Rev Cancer. 2026 Feb 10:189558.
PubMed
Abstract available
Bioinformation
- RANJITH N, Khan PA, Koppolu S, Pavani S, et al
Impact of lifestyle factors on recurrence rates in non-muscle invasive bladder
cancer: A case-control study.
Bioinformation. 2025;21:4025-4027.
PubMed
Abstract available
bioRxiv
- SOOD A, Martini A, Rudzinski JK, Tholomier C, et al
Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral
Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer.
bioRxiv [Preprint]. 2026 Jan 26:2026.01.23.701130.
PubMed
Abstract available
BMC Cancer
- ZEBER-LUBECKA N, Bilski K, Dabrowska M, Goryca K, et al
Sex-related differences in gene expression in early-stage bladder cancer revealed
by whole-transcriptome sequencing.
BMC Cancer. 2026 Feb 9. doi: 10.1186/s12885-026-15666.
PubMed
Abstract available
BMC Complement Med Ther
- LIU Y, Duan L, Zhu M, Zhou Z, et al
Exploring the underlying mechanisms of Hedyotis diffusa and Scutellaria Barbata
herb pair on the prognosis and treatment efficacy of bladder cancer patients: an
integrated approach of network pharmacology and bioinformatics analysis.
BMC Complement Med Ther. 2026 Feb 13. doi: 10.1186/s12906-026-05279.
PubMed
BMC Microbiol
- TAO L, Zhao T, Xu Y, Chen W, et al
Integrative multi-cohort analysis identifies urinary microbiota as non-invasive
biomarkers of bladder cancer.
BMC Microbiol. 2026 Feb 9. doi: 10.1186/s12866-026-04829.
PubMed
Bull Cancer
- DEMIGNE JB, Ferber E, Rodrigues M, Flippot R, et al
[Perioperative durvalumab with neoadjuvant cisplatine-gemcitabine chemotherapy in
localized muscle-invasive bladder cancer].
Bull Cancer. 2026 Feb 6:S0007-4551(26)00056-1. doi: 10.1016/j.bulcan.2025.
PubMed
Cancer Med
- DOMIAN N, Mlynarczyk G, Kasacka I
Analysis of CacyBP/SIP, ERK1/2, and p38 Expression in Low- and High-Grade
Papillary Urothelial Carcinoma.
Cancer Med. 2026;15:e71649.
PubMed
Abstract available
Cancers (Basel)
- PENG Y, Wang H, Chen H, Jin Z, et al
SAPCD2 Drives Bladder Cancer Progression by Stabilizing TANK and Engaging a
CREB-PLAGL2 Feedback Loop to Sustain MAPK Signaling.
Cancers (Basel). 2026;18:535.
PubMed
Abstract available
- DEL GIUDICE F, Santarelli V, Khan A, Gad M, et al
Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in
High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre,
International, Collaborative Study from Tertiary Referral Institutions.
Cancers (Basel). 2026;18:500.
PubMed
Abstract available
Case Rep Transplant
- LONCA L, Beniac P, Necsulescu A, Teixeira-Guerra D, et al
Robot-Assisted Cystoprostatectomy for Muscle-Invasive Bladder Cancer in a Patient
With a Prior Simultaneous Pancreas-Kidney Transplantation.
Case Rep Transplant. 2026;2026:9534770.
PubMed
Abstract available
Cells
- YUTKIN V, Maalouf N, Gur C, Zini A, et al
Targeting Bladder Cancer with Inactivated Uropathogenic E. coli: A Novel
Alternative to BCG Immunotherapy.
Cells. 2026;15:229.
PubMed
Abstract available
Clin Cancer Res
- KATIMS AB, White C, Alam SM, Farha M, et al
Urinary Biomarkers Objectively Measure Minimal Residual Disease in
Non-Muscle-Invasive Bladder Cancer.
Clin Cancer Res. 2026 Feb 9. doi: 10.1158/1078-0432.CCR-25-3395.
PubMed
Abstract available
- MIRKHESHTI N, Kpormegbey DE, Weinstock C, Gao X, et al
FDA Approval Summary: Durvalumab for the Treatment of Adult Patients with Muscle
Invasive Bladder Cancer.
Clin Cancer Res. 2026 Feb 12. doi: 10.1158/1078-0432.CCR-25-3609.
PubMed
Abstract available
Crit Rev Oncol Hematol
- ABU-GHANEM Y, Laszkiewicz J, Chan HT, Krajewski W, et al
Impact of pelvic lymph node dissection on oncological outcomes in patients with
clinically staged non-muscle-invasive bladder cancer undergoing radical
cystectomy: A systematic review.
Crit Rev Oncol Hematol. 2026;220:105192.
PubMed
Abstract available
Curr Opin Urol
- PERRI D, Roche JB, Petrut B, Bozzini G, et al
Bladder diverticula management - conservative and surgical outcomes: a narrative
review from EAU endourology.
Curr Opin Urol. 2026;36:79-85.
PubMed
Abstract available
- ST-LAURENT MP, Black PC
The challenge of bladder preservation in muscle invasive bladder cancer: key
concepts and future directions.
Curr Opin Urol. 2026 Jan 30. doi: 10.1097/MOU.0000000000001369.
PubMed
Abstract available
Curr Urol
- HARLAND N, Reitnauer LE, Amend B, Bahlinger V, et al
Significant differences in CD276 (B7H3) expression between female and male
bladder cancer tissue samples: An exploratory study.
Curr Urol. 2026;20:125-126.
PubMed
- SUN X, Jia D, Song X, Jiang Y, et al
Revealing the function and mechanism of piRNA-related genes in bladder cancer
through single-cell sequencing and methylation analyses and construction of
prognostic features based on consensus clustering.
Curr Urol. 2026;20:101-116.
PubMed
Abstract available
- CASALE P, Hurle R, Buffi NM, Lughezzani G, et al
Efficacy of early intravesical instillation of hyaluronic acid after
transurethral resection of non-muscle-invasive bladder cancers: An open-label,
prospective, single-center, randomized, controlled and parallel-group pilot
study.
Curr Urol. 2026;20:117-124.
PubMed
Abstract available
Curr Urol Rep
- WAN E, Wade C, Sathe A, Ferguson JE 3rd, et al
Contemporary Role for Blue Light Cystoscopy Across the Bladder Cancer Disease
Spectrum.
Curr Urol Rep. 2026;27:13.
PubMed
Abstract available
Discov Oncol
- SONG YX, Xia XL, Wu ZM, Yao Y, et al
Integration of bulk and single-cell transcriptomic sequencing reveals the
neutrophil heterogeneity in bladder cancer and establishes a prognostic model.
Discov Oncol. 2026 Feb 14. doi: 10.1007/s12672-026-04559.
PubMed
- QIN M, Xie G, Xie H, Lin B, et al
Development and validation of a novel senescence-associated gene signature for
prediction of survival and endocrine-disrupting chemicals in bladder cancer.
Discov Oncol. 2026 Feb 7. doi: 10.1007/s12672-026-04611.
PubMed
Eur Urol Focus
- SJODAHL G, Eriksson P, Hoglund M
Re: Joshua J. Meeks. Urothelial Cancer: What Is the Role of Expression-based
Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer? Eur Urol
Focus. In press. https://doi.org/10.1016/j.euf.2025.11.014.
Eur Urol Focus. 2026 Feb 12:S2405-4569(26)00012.
PubMed
Eur Urol Oncol
- CONTIERI R, Paciotti M, Uleri A, Saita A, et al
Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected
Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective
HuNIRe Trial.
Eur Urol Oncol. 2026 Feb 6:S2588-9311(26)00031-3. doi: 10.1016/j.euo.2026.
PubMed
Abstract available
FASEB J
- LIU ZX, Shi YY, Zhou DS, Chen SN, et al
Role of MED15 in Enhancing EMT and Metastasis in Bladder Cancer Through YAP1
Stabilization.
FASEB J. 2026;40:e71558.
PubMed
Abstract available
- CHEN H, Peng Y, Ji Z, Dong J, et al
SPP1(+) Macrophage-POSTN(+) Fibroblast-Endothelial Triad Dictates Immunotherapy
Response in Bladder Cancer.
FASEB J. 2026;40:e71546.
PubMed
Abstract available
Front Immunol
- LI A, Zhao K, Wang T, Shi G, et al
Transcriptome and single-cell RNA sequencing analysis with 101 machine learning
combinations and experimental verification reveals the mechanism of action of
mannose metabolism in bladder cancer.
Front Immunol. 2026;17:1710823.
PubMed
Abstract available
Front Oncol
- LI L, Li Q, Liu J, Wang Y, et al
Integrated single-cell and spatial transcriptomics combined with whole-exome
sequencing reveal key hub genes and epithelial heterogeneity in bladder cancer.
Front Oncol. 2026;15:1748105.
PubMed
Abstract available
- ZHANG X, Su S, Liu L, Song F, et al
Preoperative fibrinogen-to-lymphocyte ratio as a prognostic biomarker for
non-muscle-invasive bladder cancer.
Front Oncol. 2026;16:1707696.
PubMed
Abstract available
Future Sci OA
- MANIVASAGAM SS, Kassim A, Raman JD
Diagnosis, evaluation, and management of patients with non-muscle invasive
bladder cancer.
Future Sci OA. 2026;12:2622297.
PubMed
Abstract available
Int J Mol Sci
- BUTT UA, De Biase D
Correction: Butt, U.A.; De Biase, D. The Urinary Microbiota and the Gut-Bladder
Axis in Bladder Cancer. Int. J. Mol. Sci. 2025, 26, 10558.
Int J Mol Sci. 2026;27:1521.
PubMed
Abstract available
Int J Urol
- YAJIMA S, Yoshida S, Chen W, Fukushima H, et al
Comparison of Perioperative Chemotherapy Regimens for Muscle-Invasive Bladder
Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials.
Int J Urol. 2026;33:e70380.
PubMed
iScience
- ROLLIN P, Pluskwa B, Artru E, Le Vaslot T, et al
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific
CD4(+) Th1 responses.
iScience. 2026;29:114676.
PubMed
Abstract available
J Cancer Surviv
- BAHLBURG H, Rausch P, Tully KH, Berg S, et al
Psychosocial distress after radical prostatectomy, radical cystectomy, or
(partial) nephrectomy - a comprehensive analysis of 4,290 German cancer patients
during the COVID-19 pandemic.
J Cancer Surviv. 2026;20:181-188.
PubMed
Abstract available
J Clin Med
- KOCAK T, Ozbek YD, Bodur M, Yesil S, et al
Intersection of Precision Nutrition and Bladder Cancer: A Narrative
State-of-the-Art Review of Potential Applications and Challenges.
J Clin Med. 2026;15:1247.
PubMed
Abstract available
J Coll Physicians Surg Pak
- DINCER E, Ozkaptan O, Canakci C, Ipek OM, et al
The Modified Frailty Index-5 as a Predictor of Postoperative Complications
Following Radical Cystectomy.
J Coll Physicians Surg Pak. 2026;36:258-262.
PubMed
Abstract available
J Environ Pathol Toxicol Oncol
- GAO C, Cao X, Miao L, Chen W, et al
lncRNA FENDRR as a Prognostic Biomarker and Regulator of Bladder Cancer
Progression via the miR-18a-5p/ESR1 Axis.
J Environ Pathol Toxicol Oncol. 2026;45:1-12.
PubMed
Abstract available
J Exp Clin Cancer Res
- KONG Y, Li Y, An M, Luo Y, et al
Correction: ZEB1-mediated biogenesis of circnipbl sustains the metastasis of
bladder cancer via Wnt/beta-catenin pathway.
J Exp Clin Cancer Res. 2026;45:39.
PubMed
- LOCATELLI I, Lorenzoni M, Venegoni C, Di Coste A, et al
PD1-IL2v expands and induces effector CD8(+) TILs, but not Tregs, in the BCG
treated orthotopic non-muscle invasive bladder cancer model.
J Exp Clin Cancer Res. 2026 Feb 11. doi: 10.1186/s13046-026-03667.
PubMed
J Nutr Health Aging
- KLINGLMAIR G, Lutz M, Telia T, van Creij NCH, et al
Sarcopenia and recurrence risk in high-risk non-muscle-invasive bladder cancer: a
nonlinear modeling approach.
J Nutr Health Aging. 2026;30:100805.
PubMed
Abstract available
J Robot Surg
- FUKUSHIMA H, Yoshida S, Yajima S, Chen W, et al
A multi?criteria decision analysis comparing robot?assisted, laparoscopic, and
open radical cystectomy using large-scale Japanese nationwide databases.
J Robot Surg. 2026;20:230.
PubMed
Abstract available
J Transl Med
- SORENSEN EE, Frydendahl A, Rasmussen MH, Nordentoft I, et al
Molecular residual disease assessment in colorectal and bladder cancer by somatic
structural variant analysis of cell-free DNA whole-genome sequencing data.
J Transl Med. 2026 Feb 9. doi: 10.1186/s12967-026-07762.
PubMed
- XIE H, Liao T, Tang H, Ban C, et al
The GFPT2/O-GlcNAcylation/c-Myc axis promotes bladder cancer progression.
J Transl Med. 2026 Feb 7. doi: 10.1186/s12967-026-07811.
PubMed
J Urol
- ELIAS R, Aragaki AK, Hoffman-Censits JH, Hahn NM, et al
Intratumoral Expression of a Composite B Cell / CD8 T Cell Biomarker Stratifies
Overall Survival by Circulating Tumor DNA Status and Benefit From Adjuvant
Immunotherapy in High-Risk Muscle-Invasive Urothelial Carcinoma.
J Urol. 2026;215:294-304.
PubMed
Abstract available
- ZHAO D, Khatri VM, Nakashima JY, Chadha J, et al
Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients
Undergoing Bladder-Preserving Trimodality Therapy.
J Urol. 2026;215:305-315.
PubMed
Abstract available
- LAZAROVICH A, Nusbaum DJ, Agarwal PK, Modi PK, et al
Clinical Trial Design for Bacillus Calmette-Guerin-Unresponsive Non-Muscle
Invasive Bladder Cancer-Single-Arm Design Was Necessary, Randomized Trials Are
Now Essential.
J Urol. 2026 Feb 11:101097JU0000000000004960. doi: 10.1097/JU.0000000000004960.
PubMed
- ANDERSON CB, Sfakianos JP
Circulating Tumor DNA in Bladder Cancer: A New Treatment Paradigm?
J Urol. 2026;215:256-257.
PubMed
- REZAEE ME, Higgins MI, Su ZT, Sepehri S, et al
Results from the ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care
(EMBRACE) Randomized Controlled Trial.
J Urol. 2026 Feb 9:101097JU0000000000004983. doi: 10.1097/JU.0000000000004983.
PubMed
Abstract available
Jpn J Clin Oncol
- IWATANI K, Urabe F, Mori K, Nakano J, et al
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or
metastatic urothelial carcinoma: a multicenter Japanese cohort study.
Jpn J Clin Oncol. 2026;56:234-240.
PubMed
Abstract available
- YAJIMA S, Yoshida S, Chen W, Hirose K, et al
Bayesian reanalysis of avelumab maintenance therapy in Asian and Japanese
patients with advanced urothelial carcinoma: evidence from the JAVELIN Bladder
100 trial.
Jpn J Clin Oncol. 2026;56:216-220.
PubMed
Abstract available
medRxiv
- KUMAR P, Alarid-Escudero F, Chiddarwar TV, Garibay-Trevino DU, et al
Differences in Bladder Cancer Diagnosis by Demographic Factors: A Simulation
Modeling Analysis.
medRxiv [Preprint]. 2026 Feb 2:2026.01.30.26344972.
PubMed
Abstract available
Mol Omics
- CARAPITO A, Sousa TV, Teixeira-Marques A, Henrique R, et al
Urinary Metabolomics Identifies Lactate as a Biomarker for Bladder Cancer
Detection and Progression.
Mol Omics. 2026 Feb 9:aaiag004. doi: 10.1093.
PubMed
Abstract available
Molecules
- RUTZ J, Grein T, Laqua M, Benhassine K, et al
Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and
Cisplatin-Resistant Bladder Cancer Cell Lines.
Molecules. 2026;31:555.
PubMed
Abstract available
N Engl J Med
-
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
N Engl J Med. 2026;394:728.
PubMed
Neoplasia
- GAO M, Li C, Li W, Xie J, et al
White-to-brown adipose switching promotes bladder cancer progression.
Neoplasia. 2026;73:101282.
PubMed
Abstract available
Phys Med
- HERCZEG BT, Sudar A, Ortutay R, Agoston P, et al
Risk estimations of radiation induced malignancies in rectum and bladder
following radiotherapy of prostate carcinoma.
Phys Med. 2026;142:105714.
PubMed
Abstract available
PLoS Biol
- GAO X, Yu Y, Sun J, Zhao H, et al
CUL5 E3 ubiquitin ligase regulates the evasion of bladder cancer cells to CD8+ T
cell-mediated killing by inhibiting autophagy.
PLoS Biol. 2026;24:e3003647.
PubMed
Abstract available
Radiother Oncol
- MICHALET M, Ronchin P, Reynaud T, Demogeot N, et al
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin
alone for organ preservation in muscle-invasive bladder cancer: results of the
GETUG V04 randomized phase II trial.
Radiother Oncol. 2026;217:111443.
PubMed
Abstract available
Research (Wash D C)
- ZHANG G, Wang L, Zhao G, Huang Y, et al
Hypoxia-Induced TGFBI Promotes Bladder Cancer Progression by Creating a Stemness
Regulation Loop through Stabilizing the Disulfide Bonds of GDF15.
Research (Wash D C). 2026;9:1134.
PubMed
Abstract available
Sci Rep
- ZHANG Q, Guo Y, Lin F, Zuo Y, et al
?CT image-derived radiomics predicts molecular subtypes in bladder urothelial
carcinoma: validation of a non-invasive classification strategy.
Sci Rep. 2026;16:6016.
PubMed
Abstract available
- WANG X, Guo J, Zhang R, Dong Y, et al
Hypoxia-inducible factor 1alpha exerts dual roles in bladder cancer progression
through TIMP3-mediated regulation of angiogenesis and invasion.
Sci Rep. 2026 Feb 12. doi: 10.1038/s41598-026-39635.
PubMed
Abstract available
- LIN N, Chen L, Zhang Y, Yang Y, et al
Retraction Note: KIF4A promotes tumor progression of bladder cancer via CXCL5
dependent myeloid-derived suppressor cells recruitment.
Sci Rep. 2026;16:5741.
PubMed
Support Care Cancer
- HUANG X, Chen R, Guo Z, Song C, et al
Intensive nursing interventions for post-treatment anxiety and depression in
bladder cancer: A systematic review and meta-analysis.
Support Care Cancer. 2026;34:195.
PubMed
Abstract available
Surg Oncol
- UTLU A, Aksakalli T, Celik F, Cinislioglu AE, et al
HALP score as an independent prognostic biomarker for recurrence and progression
in non-muscle-invasive bladder cancer: A retrospective cohort study.
Surg Oncol. 2026;65:102357.
PubMed
Abstract available
Transl Androl Urol
- ZHAO L, Yang JW, Chen SY, Wang L, et al
Immune checkpoint inhibitors in BCG-unresponsive non-muscle-invasive bladder
cancer: a narrative review of evidence and future directions.
Transl Androl Urol. 2026;15:29.
PubMed
Abstract available
- ZHOU H, Ge Z, Lin S, Wu Y, et al
Application of serum miRNA panel in bladder cancer detection.
Transl Androl Urol. 2026;15:23.
PubMed
Abstract available
- JIA B, Rao B, Chen R, Cui K, et al
Overview of tumor-resident intratumoral microbiota in human bladder cancer.
Transl Androl Urol. 2026;15:19.
PubMed
Abstract available
Tzu Chi Med J
- KUNG TC, Jiang YH, Kuo HC
Prognostic factors for the recurrence, progression, and multiple recurrences of
non-muscle-invasive bladder cancer in Eastern Taiwan.
Tzu Chi Med J. 2025;38:83-89.
PubMed
Abstract available
Urol Oncol
- GARG T, Negron-Candelario S, Miller H, Demirsoy S, et al
Adapting patient priorities care for older adults with non-muscle-invasive
bladder cancer: A qualitative inquiry.
Urol Oncol. 2026;44:110996.
PubMed
Abstract available
- ELSAWY AA, Laymon M, Ezzat O, Mansour I, et al
Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive
bladder cancer; oncological and patient-reported outcomes of randomized
controlled trial.
Urol Oncol. 2026;44:111006.
PubMed
Abstract available
- SCILIPOTI P, Rosiello G, Santangelo A, Viti A, et al
Optimizing oncological outcomes in high-grade non-muscle invasive bladder cancer:
The impact of a surgeon-led treatment pathway.
Urol Oncol. 2026;44:111007.
PubMed
Abstract available
Urologie
- LEEDER M, Leucht K, Marx M, Grimm MO, et al
[Treatment of non-muscle-invasive bladder cancer].
Urologie. 2026 Feb 9. doi: 10.1007/s00120-026-02781.
PubMed
Abstract available
- ESCOBAR D, Doshi C, Zahir M, Daneshmand S, et al
Modern management of BCG-refractory non-muscle-invasive urothelial carcinoma of
the urinary bladder.
Urologie. 2026;65:162-170.
PubMed
Abstract available
Urology
- SMITH AB, Gore JL, Chisolm S, Squires P, et al
Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging
Treatment Era: A Patient Preference Study.
Urology. 2026 Feb 11:S0090-4295(26)00092-0. doi: 10.1016/j.urology.2026.
PubMed
Abstract available
- HJORT PB, Hyldgaard JM, Young-Halvorsen K, Husch T, et al
Association between Photodynamic diagnosis and risk of recurrence and progression
in BCG-treated non-muscle invasive bladder cancer patients: a nationwide
follow-up study.
Urology. 2026 Feb 10:S0090-4295(26)00091-9. doi: 10.1016/j.urology.2026.
PubMed
Abstract available
- APONTE-COLON DA, Wilcox Vanden Berg R, Tua-Caraccia R, Kim JK, et al
Clinical Characteristics, Recurrence, and Survival for Children and Young Adults
With Urothelial Cancer: A Systematic Review.
Urology. 2026;208:135-141.
PubMed
Abstract available
Zhong Nan Da Xue Xue Bao Yi Xue Ban
- WANG Y, Liu L, Li M
Toxic epidermal necrolysis associated with immune checkpoint inhibitors for
bladder cancer: A case report.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025;50:2031-2037.
PubMed
Abstract available
FAQ
